Richard E. Royal
Impact in
- Oncology top 0.1%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Immunology top 0.2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
- Co-authors
- Steven A. Rosenberg (22 shared papers)Richard M. Sherry (17 shared papers)Udai S. Kammula (19 shared papers)Marybeth S. Hughes (20 shared papers)James Chih‐Hsin Yang (14 shared papers)Suzanne L. Topalian (12 shared papers)Catherine Lévy (8 shared papers)Sharon Mavroukakis (7 shared papers)
- Journals
- Journal of Clinical Oncology (24 papers)Annals of Surgical Oncology (18 papers)Journal of Immunotherapy (7 papers)Clinical Cancer Research (4 papers)Annals of Surgery (3 papers)
- Partner nations
- United StatesAustraliaNetherlands
In The Last Decade
Richard E. Royal
98 papers receiving 11.0k citations
Richard E. Royal's Hit Papers
Peers
Comparison fields: 5 of 114
- Oncology 7.3k
- Immunology 5.0k
- Genetics 1.2k
- Cancer Research 462
- Pulmonary and Respiratory Medicine 939
Countries citing papers authored by Richard E. Royal
This map shows the geographic impact of Richard E. Royal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard E. Royal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard E. Royal more than expected).
Fields of papers citing papers by Richard E. Royal
This network shows the impact of papers produced by Richard E. Royal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard E. Royal. The network helps show where Richard E. Royal may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard E. Royal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes Hit paper breakdown → | 2006 | 1977 |
| 2 | Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens Hit paper breakdown → | 2008 | 1022 |
| 3 | Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma Hit paper breakdown → | 2010 | 973 |
| 4 | Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4 Hit paper breakdown → | 2005 | 773 |
| 5 | Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4 Hit paper breakdown → | 2006 | 645 |
| 6 | Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis Hit paper breakdown → | 2007 | 542 |
| 7 | Prognostic Factors Related to Clinical Response in Patients with Metastatic Melanoma Treated by CTL-Associated Antigen-4 Blockade Hit paper breakdown → | 2007 | 521 |
| 8 | 2005 | 381 | |
| 9 | 2005 | 365 | |
| 10 | 2008 | 323 | |
| 11 | 2005 | 276 | |
| 12 | 1997 | 267 | |
| 13 | 2010 | 223 | |
| 14 | 2006 | 214 | |
| 15 | Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. | 1996 | 189 |
| 16 | 2008 | 179 | |
| 17 | 2007 | 122 | |
| 18 | 2010 | 120 | |
| 19 | 2013 | 106 | |
| 20 | 2015 | 103 |
About Richard E. Royal
Richard E. Royal is a scholar working on Oncology, Surgery, Immunology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 100 papers that have together received 11.2k indexed citations. Recurring topics across this work include Intraperitoneal and Appendiceal Malignancies (31 papers), Immunotherapy and Immune Responses (16 papers), Cancer Immunotherapy and Biomarkers (15 papers), CAR-T cell therapy research (12 papers), Cutaneous Melanoma Detection and Management (11 papers), T-cell and B-cell Immunology (6 papers), vaccines and immunoinformatics approaches (5 papers) and Ovarian cancer diagnosis and treatment (4 papers). The work is most often cited by research in Oncology (7.3k citations), Immunology (5.0k citations), Genetics (1.2k citations), Cancer Research (462 citations) and Pulmonary and Respiratory Medicine (939 citations). Richard E. Royal has collaborated with scholars based in United States, Australia and Netherlands. Frequent co-authors include Steven A. Rosenberg, Richard M. Sherry, Udai S. Kammula, Marybeth S. Hughes, James Chih‐Hsin Yang, Suzanne L. Topalian, Catherine Lévy, Sharon Mavroukakis, Nicholas P. Restifo and Donald E. White. Their work appears in journals such as Journal of Clinical Oncology, Annals of Surgical Oncology, Journal of Immunotherapy, Clinical Cancer Research and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.